Stocktoria
BIO-RAD LABORATORIES, INC. BIO
NYSE · XNYS · stock · Laboratory Analytical Instruments · website · IPO 1980-03-17
BIO-RAD LABORATORIES, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 51.9% | 53.7% | 53.4% | 55.9% | 56.1% |
| Operating margin | 1.8% | 10.5% | 12.6% | 17.2% | 17.1% |
| Net margin | 29.4% | -71.9% | -23.9% | -129.5% | 145.6% |
| FCF margin | 14.5% | 11.3% | 8.2% | 2.9% | 18.3% |
| Return on assets | 7.2% | -19.7% | -5.2% | -26.9% | 23.9% |
| Return on equity | 10.2% | -28.1% | -7.3% | -37.7% | 31.1% |
| Debt / equity | 0.16× | 0.18× | 0.14× | 0.12× | 0.00× |
| Current ratio | 5.62 | 6.48 | 5.83 | 5.55 | 2.92 |
| Revenue growth | 0.7% | -3.9% | -4.7% | -4.1% | 14.8% |
Source: SEC EDGAR filings · CIK 0000012208 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.